Phase III study of maintenance gemcitabine (G) and best supportive care (BSC) versus BSC, following standard combination therapy with gemcitabine-carboplatin (G-Cb) for patients with advanced non-small cell lung cancer (NSCLC).
2010 ◽
Vol 28
(15_suppl)
◽
pp. 7506-7506
◽
Keyword(s):
Keyword(s):
2009 ◽
Vol 27
(18S)
◽
pp. CRA8000-CRA8000
◽
Keyword(s):
Keyword(s):
1999 ◽
Vol 35
◽
pp. S246
◽
Keyword(s):
2011 ◽
Vol 29
(15_suppl)
◽
pp. CRA7510-CRA7510
◽
Keyword(s):
Keyword(s):
Keyword(s):
2009 ◽
Vol 27
(15_suppl)
◽
pp. CRA8000-CRA8000
Keyword(s):
Keyword(s):